Attention deficit-hyperactivity disorder (ADHD) has been a common psychiatric diagnosis in both children and adults since the 1980s and 1990s in the United States. But the diagnosis was much less common-even unknown-in other parts of the world. By the end of the twentieth century, this was no longer the case, and ADHD diagnosis and treatment became an increasingly widespread global phenomenon. As the diagnosis was adopted around the world, the definition and treatment of ADHD often changed in the context of different psychiatric professions, medical systems, and cultures. Global Perspectives on ADHD is the first book to examine how this expanding public health concern is diagnosed and treated in 16 different countries. In some countries, readers learn, over 10% of school-aged children and adolescents are diagnosed with ADHD; in others, that figure is less than 1%. Some countries focus on medicating children with ADHD; others emphasize parent intervention or child therapy. Showing how a medical diagnosis varies across contexts and time periods, this book explains how those distinctions shape medical interventions and guidelines, filling a much-needed gap by examining ADHD on an international scale. Contributors: Madeleine Akrich, Mari J. Armstrong-Hough, Meredith R. Bergey, Eugenia Bianchi, Christian Broer, Peter Conrad, Claire Edwards, Silvia A. Faraone, Angela M. Filipe, Alessandra Frigerio, Valeria Portugal Goncalves, Linda J. Graham, Hiroyuki Ito, Fabian Karsch, Victor Kraak, Claudia Malacrida, Lorenzo Montali, Yasuo Murayama, Sebastian Rojas Navarro, Orla O'Donovan, Francisco Ortega, Monica Pena Ochoa, Brenton J. Prosser, Vololona Rabeharisoa, Patricio Rojas, Tiffani Semach, Ilina Singh, Rachel Spronk, Junko Teruyama, Masatsugu Tsujii, Fan-Tzu Tseng, Manuel Vallee, Rafaela Zorzanelli

Many decisions in the legal system and elsewhere depend on predictions of bad behaviors, including crimes and mental illnesses. Some scientists have suggested recently that these predictions can become more accurate and useful if they are based in part on biological information, such as brain structure and function, genes, and hormones. The prospect of such bioprediction, however, raises serious concerns about errors and injustice. Can biological information significantly increase the accuracy of predictions of bad behavior? Will innocent or harmless people be mistakenly treated as if they were guilty or dangerous? Is it fair to keep people in prisons or mental institutions longer because of their biology? Will these new instruments of bioprediction be abused in practice within current institutions? Is bioprediction worth the cost? Do we want our government to use biology in this way? All of these scientific, legal, and ethical questions are discussed in this volume. The contributors are prominent neuroscientists, psychologists, sociologists, philosophers, ethicists, and legal scholars. This volume will interest everyone with hopes that bioprediction will solve problems or fears that bioprediction will be applied unjustly.

Global Mental Health and Neuroethics explores conceptual, ethical and clinical issues that have emerged with the expansion of clinical neuroscience into middle- and low-income countries. Conceptual issues covered include avoiding scientism and skepticism in global mental health, integrating evidence-based and value-based global medicine, and developing a welfarist approach to the practice of global psychiatry. Ethical issues addressed include those raised by developments in neurogenetics, cosmetic psychopharmacology and deep brain stimulation. Perspectives drawing on global mental health and neuroethics are used to explore a number of different clinical disorders and developmental stages, ranging from childhood through to old age.